{"schema_version":"secwatch.filing_event.v1","accession":"0001171520-22-000313","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2022-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.084788+00:00","generated_at":"2026-06-25T09:05:50.596866+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ClearPoint Neuro receives Nasdaq non-compliance notice, cures by reconstituting committees","bullets":["Nasdaq notified ClearPoint Neuro on May 19, 2022 of non-compliance with audit and compensation committee independence rules due to Matthew Klein, M.D. not being independent.","Board reconstituted committees on May 13, 2022: Audit now has Pascal Girin, Lynnette Fallon, R. John Fletcher; Compensation has B. Kristine Johnson and Timothy Richards.","Nasdaq confirmed the company now complies with Listing Rule 5605 following committee changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001171520-22-000313","json":"https://secwatch.observer/filing/0001171520-22-000313.json","markdown":"https://secwatch.observer/filing/0001171520-22-000313.md","text":"https://secwatch.observer/filing/0001171520-22-000313.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000313/0001171520-22-000313-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000313/eps10266.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T09:05:50.596866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}